Cardiac sarcoidosis

Internal Medicine Journal

Volumn 38, Issue 4, 2008, Pages 270-277

  Habersberger, J ^a,b   Manins, V ^a   Taylor, A J ^a  

^a ALFRED HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Cardiac; MRI; Sarcoid

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; GALLIUM 67; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ARTIFICIAL HEART PACEMAKER; CELLULAR IMMUNITY; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DIAGNOSTIC TEST; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART MUSCLE BIOPSY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART TAMPONADE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; LOW DRUG DOSE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; REVIEW; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; SURVIVAL RATE; SYSTOLIC DYSFUNCTION; UNSPECIFIED SIDE EFFECT; VALVULAR HEART DISEASE;

ADULT; CARDIOMYOPATHIES; HUMANS; PROGNOSIS; SARCOIDOSIS;

EID: 41549086262     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01590.x     Document Type: Review

References (35)

1. Hutchinson J. Cases of Mortimer's Malady. Arch Surg 1898 9 : 307.
2. Bernstein M. Boeck's sarcoid: report of a case with visceral involvement. Arch Intern Med 1929 44 : 721 34.
3. Marshman RS. Prevalence of pulmonary sarcoidosis in the state of Victoria, Australia. Acta Med Scand Suppl 1964 425 : 167 8.
4. Gillman A, Steinfort C. Sarcoidosis in Australia. Intern Med J 2007 37 : 356 9.
5. Roberts WC, McAllister HA Jr., Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977 63 : 86 108.
6. Nelson JE, Kirschner PA, Teirstein AS. Sarcoidosis presenting as heart disease. Sarcoidosis Vasc Diffuse Lung Dis 1996 13 : 178 82.
7. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978 58 : 1204 11.
8. Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976 278 : 455 69.
9. Fleming HA. Cardiac sarcoidosis. Sarcoidosis 1991 8 : 167 8.
10. Winters SL et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991 18 : 937 43.
11. Yazaki Y, Isobe M, Hiramitsu S, Morimoto S, Hiroe M, Omichi C et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 1998 82 : 537 40.
12. Hiraga H, Yuwai K, Hiroe M et al. Guideline for the Diagnosis of Cardiac Sarcoidosis Study Report on Diffuse Pulmonary Diseases. Tokyo, Japan : The Japanese Ministry of Health and Welfare 1993 23 4 (in Japanese).
13. Sekiguchi M, Hiroe M, Take M, Hirosawa K. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J 1980 44 : 249 63.
14. Abeler V. Sarcoidosis of the cardiac conducting system. Am Heart J 1979 97 : 701 7.
15. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001 88 : 1006 10.
16. Burstow DJ, Tajik AJ, Bailey KR, DeRemee RA, Taliercio CP. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 1989 63 : 478 82.
17. Bulkley BH, Rouleau JR, Whitaker JQ, Strauss HW, Pitt B. The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest 1977 72 : 27 32.
18. Kinney EL, Jackson GL, Reeves WC, Zelis R. Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients. Am J Med 1980 68 : 497 503.
19. Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995 107 : 330 34.
20. Kaminaga T, Takeshita T, Yamauchi T, Kawamura H, Yasuda M. The role of iodine-123-labeled 15-(p-iodophenyl)-3R, S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Intern J Cardiol 2004 94 : 99 103.
21. Alberts C, van der Schoot JB, Groen AS. 67Ga scintigraphy as an index of disease activity in pulmonary sarcoidosis. Eur J Nucl Med 1981 6 : 205 12.
22. Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004 45 : 1989 98.
23. Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, Takeuchi K et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 2003 44 : 1030 36.
24. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999 100 : 1992 2002.
25. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005 45 : 1683 90.
26. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998 97 : 1802 9.
27. Schulz-Menger J, Wassmuth R, Abdel-Aty H, Siegel I, Franke A, Dietz R et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart 2006 92 : 399 400.
28. Vignaux O, Dhote R, Duboc D, Blanche P, Dusser D, Weber S et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002 122 : 1895 901.
29. Shimada T, Shimada K, Sakane T, Ochiai K, Tsukihashi H, Fukui M et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001 110 : 520 27.
30. Ishikawa T, Kondoh H, Nakagawa S, Koiwaya Y, Tanaka K. Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest 1984 85 : 445 7.
31. Furushima H, Cinushi M, Sugiura H, Kasai H, Washizuka T, Aizawa Y. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol 2004 27 : 217 22.
32. Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 2005 96 : 276 82.
33. Valantine HA, Tazelaar HD, Macoviak J, Mullin AV, Hunt SA, Fowler MB et al. Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant 1987 6 : 244 50.
34. Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 1992 11 (2 Pt 1 367 9.
35. Burke WM, Keogh A, Maloney PJ, Delprado W, Bryant DH, Spratt P. Transmission of sarcoidosis via cardiac transplantation. Lancet 1990 336 : 1579.